Bleakley Financial Group, LLC Apellis Pharmaceuticals, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 73,505 shares of APLS stock, worth $2.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
73,505
Previous 78,956
6.9%
Holding current value
$2.1 Million
Previous $2.28 Billion
3.01%
% of portfolio
0.07%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding APLS
# of Institutions
304Shares Held
109MCall Options Held
3.87MPut Options Held
1.12M-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$339 Million14.88% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$336 Million0.07% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$317 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$286 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$165 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.13B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...